Mee Y. Bartee

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses”.

Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses

PLoS ONE(2020)10.1371/journal.pone.0231977

N/A

0DataRank · unranked

8 citations

Mee Y. Bartee, Eric Bartee, Erica Flores

Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006388

N/A

0DataRank · unranked

9 citations

Heather D. Curtsinger, Mee Y. Bartee, Eric Bartee, Parker Dryja

Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection

Molecular Therapy — Oncolytics(2023)10.1016/j.omto.2023.08.014

N/A

0DataRank · unranked

7 citations

Mee Y. Bartee, Miriam Valenzuela-Cardenas, Eric Bartee, Raquela J. Thomas

IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200866

N/A

0DataRank · unranked

4 citations

Carrie Fisher, Mee Y. Bartee, Eric Bartee, Miriam Valenzuela-Cardenas

Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levels

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201066

N/A

0DataRank · unranked

0 citations

Erica Flores, Mee Y. Bartee, Viswanathan Palanisamy, Eric Bartee, Parker Dryja